Hsbc Holdings PLC Dexcom Inc Put Options Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $6.71 Million - $12.2 Million	-104,900 Reduced 37.2%	177,100 $11.9 Million
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $26.3 Million - $33.5 Million	238,800 Added 552.78%	282,000 $32 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $6.13 Million - $7.52 Million	-53,700 Reduced 55.42%	43,200 $5.99 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $3.64 Million - $5.98 Million	-48,200 Reduced 33.22%	96,900 $12 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $5.74 Million - $9.2 Million	66,700 Added 85.08%	145,100 $13.5 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $8.82 Million - $10.3 Million	78,400 New	78,400 $10.1 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.